Matthew Frank
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies (NCT04088890) | Matthew Frank | 2019-09-12 |
Track Matthew Frank automatically
Every clearance here is in the API, with alerts when new ones post.